News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
686,593 Results
Type
Article (60888)
Company Profile (205)
Press Release (625500)
Section
Business (189118)
Career Advice (3276)
Deals (34610)
Drug Delivery (118)
Drug Development (81304)
Employer Resources (176)
FDA (17268)
Job Trends (15640)
News (334499)
Policy (35670)
Tag
Academia (2863)
Alliances (50285)
Alzheimer's disease (1372)
Approvals (17202)
Artificial intelligence (178)
Bankruptcy (359)
Best Places to Work (11846)
Biotechnology (133)
Breast cancer (211)
Cancer (1592)
Cardiovascular disease (137)
Career advice (2764)
CAR-T (122)
Cell therapy (339)
Clinical research (65015)
Collaboration (587)
Compensation (200)
COVID-19 (2759)
C-suite (143)
Data (1478)
Diabetes (198)
Diagnostics (6462)
Earnings (69319)
Employer resources (154)
Events (94084)
Executive appointments (490)
FDA (18061)
Funding (531)
Gene therapy (242)
GLP-1 (718)
Government (4771)
Healthcare (19171)
Infectious disease (2865)
Inflammatory bowel disease (124)
Interviews (637)
IPO (15710)
Job creations (4193)
Job search strategy (2288)
Layoffs (488)
Legal (8895)
Lung cancer (240)
Manufacturing (239)
Medical device (13276)
Medtech (13281)
Mergers & acquisitions (19135)
Metabolic disorders (547)
Neuroscience (1766)
NextGen: Class of 2025 (6929)
Non-profit (4939)
Northern California (1752)
Obesity (316)
Opinion (249)
Patents (139)
People (55292)
Phase I (19938)
Phase II (28455)
Phase III (21809)
Pipeline (632)
Postmarket research (2643)
Preclinical (8493)
Radiopharmaceuticals (242)
Rare diseases (310)
Real estate (6298)
Regulatory (23685)
Research institute (2594)
Resumes & cover letters (511)
Southern California (1513)
Startups (3755)
United States (15793)
Vaccines (661)
Weight loss (239)
Date
Last 7 days (672)
Last 30 days (1815)
Last 365 days (34347)
2025 (1565)
2024 (34774)
2023 (39297)
2022 (50212)
2021 (54768)
2020 (54034)
2019 (48025)
2018 (36682)
2017 (33686)
2016 (32884)
2015 (37770)
2014 (31142)
2013 (27643)
2012 (28034)
2011 (28546)
2010 (26576)
Location
Africa (1009)
Arizona (157)
Asia (42457)
Australia (7245)
California (3971)
Canada (1507)
China (366)
Colorado (194)
Connecticut (199)
Europe (94841)
Florida (587)
Georgia (139)
Illinois (438)
Indiana (231)
Maryland (649)
Massachusetts (2954)
Michigan (194)
Minnesota (279)
New Jersey (1169)
New York (1147)
North Carolina (803)
Northern California (1752)
Ohio (155)
Pennsylvania (926)
South America (1381)
Southern California (1513)
Texas (590)
Utah (127)
Washington State (409)
686,593 Results for "la jolla institute for immunology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
La Jolla Institute for Immunology and RevolKa started a Research Collaboration
RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology agreed to start a research collaboration to create antigens for the next-generation vaccines to deliver innovative solutions to unmet medical need in infectious diseases.
April 18, 2024
·
2 min read
Press Releases
Phio Pharmaceuticals Announces Publication in Frontiers in Immunology
Journal is the official publication of the International Union of Immunological Societies
December 12, 2024
·
4 min read
Business
La Jolla Institute for Immunology Acquires the Carterra LSA Platform to Advance State-of-the-Art Immunological and Infectious Disease Research
Carterra, Inc. and La Jolla Institute for Immunology (LJI) announced today that LJI has acquired a Carterra LSA instrument to enhance its antibody screening and characterization work.
August 1, 2022
·
5 min read
Biotech Beach
Equillium Announces Presentation of Data Demonstrating Biological Importance of Multi-Cytokine Inhibitors EQ101 and EQ102 at the La Jolla Immunology Conference
Equillium, Inc. today announced data presented at the annual La Jolla Immunology Conference.
October 26, 2022
·
7 min read
Press Releases
Agilent Presents Solutions Innovation Research Awards to Institut National de la Recherche Scientifique and University of Southern California Scientists
November 7, 2024
·
4 min read
XNK presents at the 8th Innate Killer Summit in La Jolla, San Diego
XNK Therapeutics AB announced its extensive participation at the 8th Annual Innate Killer Summit in La Jolla, San Diego, CA, March 28-30.
March 22, 2023
·
2 min read
Deals
Innoviva to Acquire La Jolla Pharmaceutical Company
Innoviva, Inc. and La Jolla Pharmaceutical Company announced that they have entered into a definitive merger agreement whereby Innoviva will acquire La Jolla.
July 11, 2022
·
10 min read
Business
Cytocom, Inc. and La Jolla Institute for Immunology Announce Five-Year Research Alliance Agreement
Cytocom, Inc., a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, announced a collaboration agreement to fund research and laboratory facilities at the La Jolla Institute for Immunology, a not-for-profit academic institution and a world leader in immunology research.
August 12, 2021
·
8 min read
Press Releases
The Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) Selects Indica Labs’ HALO AP to Deliver AI-enabled Diagnostics
October 31, 2024
·
4 min read
Business
La Jolla Institute renews longtime collaboration with Kyowa Kirin, Inc.
La Jolla Institute for Immunology (LJI) and Kyowa Kirin, Inc. (KKNA), a wholly-owned subsidiary of Kyowa Kirin Co., Ltd (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical company, today announced the signing of a new collaboration agreement.
January 18, 2022
·
4 min read
1 of 68,660
Next
